Literature DB >> 31679345

Multiple Sclerosis in Tehran: Rising Prevalence alongside Stabilizing Incidence - True Increase or Enhanced Diagnosis?

Farnam Mohebi1,2, Sharareh Eskandarieh1, Mohammad Ali Mansournia3, Bahram Mohajer1,2, Mohammad Ali Sahraian1.   

Abstract

BACKGROUND: Multiple sclerosis (MS) is a chronic and potentially progressive demyelinating disease of the central nervous system. The incidence and prevalence rate of the disease has been increasing globally, especially in females.
METHODS: In this cross-sectional population-based study based on Iranian MS Society data (1989-2016), we aimed to present most recent age-standardized incidence and prevalence rate of MS, female to male ratio, mean onset age, and prevalence of positive family history of MS alongside with their time trend via Joinpoint regression analysis in 27 years. Additionally, a linear regression model was used for evaluating the association of onset age with sex and family history in patients.
RESULTS: In 18,061 registered cases: female to male ratio was generally 3.06:1, showing a general decreasing trend. The mean onset age of the disease was 28.50 ± 8.61 with a general increasing trend. 12.52% of the cases had at least a positive any-degree family history of MS, exhibiting a weak increasing trend. The age-standardized incidence and prevalence rate was 1.8 (95% CI: 1.3, 7.2) and 116 (95% CI: 96, 139) per 100000 populations, respectively, both presenting a significant increasing trend, however, incidence rate ended in plateaued and finally decreasing trend. Finally, onset age was predicted to be lower in females and subjects with positive family history of MS.
CONCLUSION: Tehran is among MS high-risk areas with increasing trends in prevalence and increasing followed by plateaued incidence rates indicating necessity of extra investigations of the underlying reasons and health system preparedness for further health care requirements of MS patients.
© 2019 The Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Entities:  

Keywords:  Age of onset; Epidemiology; Incidence; Multiple sclerosis; Prevalence; Sex ratio

Mesh:

Year:  2019        PMID: 31679345

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN: 1029-2977            Impact factor:   1.354


  7 in total

Review 1.  Prevalence of multiple sclerosis (MS) in Iran: a systematic review and meta-analysis.

Authors:  Omid Mirmosayyeb; Vahid Shaygannejad; Sara Bagherieh; Ali Mahdi Hosseinabadi; Mahsa Ghajarzadeh
Journal:  Neurol Sci       Date:  2021-11-17       Impact factor: 3.307

2.  Evidence of an increased prevalence of multiple sclerosis: a population-based study of Tehran registry during 1999-2018.

Authors:  Amir Almasi-Hashiani; Mohammad Ali Sahraian; Sharareh Eskandarieh
Journal:  BMC Neurol       Date:  2020-05-02       Impact factor: 2.474

3.  Bladder Dysfunction in Iranian Patients with Multiple Sclerosis.

Authors:  Mohaddeseh Azadvari; Seyede Zahra Emami Razavi; Masumeh Shahrooei; Abdorreza Naser Moghadasi; Amirreza Azimi; Hamid Reza Farhadi-Shabestari
Journal:  J Multidiscip Healthc       Date:  2020-04-02

4.  Is the sharp increasing trend of multiple sclerosis incidence real in Iran?

Authors:  Ali Hosseinzadeh; Behnaz Sedighi; Jamshid Kermanchi; Mohammad Heidari; Ali Akbar Haghdoost
Journal:  BMC Neurol       Date:  2021-01-07       Impact factor: 2.474

5.  Fear and anxiety in patients with multiple sclerosis during COVID-19 pandemic; report of an Iranian population.

Authors:  Neda Ramezani; Fereshteh Ashtari; Elahe Abdi Bastami; Kimia Ghaderi; Sayed Mohsen Hosseini; Maryam Kazemi Naeini; Fatemeh Rajabi; Iman Adibi
Journal:  Mult Scler Relat Disord       Date:  2021-01-29       Impact factor: 4.339

Review 6.  Multiple sclerosis in Iran: An epidemiological update with focus on air pollution debate.

Authors:  Masoud Amiri
Journal:  J Clin Transl Res       Date:  2021-02-17

7.  The global prevalence of familial multiple sclerosis: an updated systematic review and meta-analysis.

Authors:  Naeim Ehtesham; Maryam Zare Rafie; Meysam Mosallaei
Journal:  BMC Neurol       Date:  2021-06-28       Impact factor: 2.474

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.